HKB's T-Cell Dependent Antibody Response (TDAR) Assays provide pharmaceutical researchers with comprehensive immunotoxicity testing capabilities for preclinical drug development. The TDAR assay serves as a gold-standard approach for evaluating the impact of therapeutic candidates on humoral immune function. Our assays measure both primary and secondary antibody responses to T-cell dependent antigens.